
Interview of EORTC members about COVID-19 impact on cancer clinical trials
4 Feb 2021

PRESS RELEASE: EORTC 1945 OligoRARE trial in oligometastatic rare cancers receives support by Anticancer Fund & Rising Tide Foundation
2 Feb 2021

PRESS RELEASE: First Patients Tested with InVisionFirst®-Lung in EORTC Sponsored Phase II NSCLC Study
20 Jan 2021

Webinar: How can current EU policy initiatives pave the way towards treatment optimisation as part of health systems?
14 Jan 2021

EORTC lobbies for reducing the economic burden of cancer by optimising treatment for cancer patients
17 Dec 2020

Pivoting from physical to virtual meetings, engaging with a global audience
17 Dec 2020

The 1553-SPECTA translational research platform registered the 1000th patient
17 Dec 2020

Genito-urinary cancer research looks to the future
2 Dec 2020